Published Erratum Ahead of print
PubMed: 42906228 DOI: 10.1016/j.ygyno.2026.10.008
Corrigendum to "Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumors" [Gynecol. Oncol. 197 (2025) 139-145].
Gynecol Oncol 214:134
Authors: Elizabeth Evans, Jhalak Dholakia, Jim Abraham, Andrew Hinton, Jian Zhang, Joanne Xiu, Todd Maney, Matt Oberley, Premal Thaker, Thomas Herzog, David Spetzler, Rebecca C Arend
Affiliations
- Mercy Hospital Coletta Cancer Center, Oklahoma City, OK, USA.
- East Carolina University Health, Greenville, NC, USA.
- Caris Life Sciences, Phoenix, AZ, USA.
- Washington University School of Medicine, St. Louis, MO, USA.
- University of Alabama at Birmingham, Birmingham, AL, USA.
MeSH
Recombination, Genetic, Homologous Recombination, Ovary, Neoplasms, Exome, Exome Sequencing